Tonix Pharmaceuticals Holding Corp TNXP shares are trading lower by 23.3% to $0.54 Friday morning after the company announced the pricing of a $4.5 million public offering of 9 million shares and warrants at $0.50 per share.
Tonix Pharmaceuticals says the gross proceeds of the offering will be approximately $4.5 million before deducting placement agent fees and other estimated offering expenses payable by the company.
Tonix Pharmaceuticals intends to use the net proceeds from the offering for working capital and general corporate purposes, the build out of the company's manufacturing and research and development facilities and the acquisition or licensing of approved products and products in development.
According to data from Benzinga Pro, TNXP has a 52-week high of $9.81 and a 52-week low of $0.49.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
